v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Series B
Preferred Stock
Common Stock
Common Stock to be Issued
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2024 $ 200 $ 308 $ 59,649,645 $ (397,969) $ (52,373,248) $ (2,137,789) $ 4,741,147
Balance (in Shares) at Dec. 31, 2024 2,000,000 3,076,274 139          
Balance (in Shares) at Dec. 31, 2024         66,945      
Accretion of stock-based compensation in connection with stock option grants 155,054 155,054
Issuance of common stock for cash, net of allocated offering costs $ 120 4,531,880 4,532,000
Issuance of common stock for cash, net of allocated offering costs (in Shares)   1,200,000            
Initial recording on noncontrolling interest 188,810 (188,810)
Net loss for the period (1,473,196) (145,914) (1,619,110)
Balance at Mar. 31, 2025 $ 200 $ 428 64,525,389 $ (397,969) (53,846,444) (2,472,513) 7,809,091
Balance (in Shares) at Mar. 31, 2025 2,000,000 4,276,274 139          
Balance (in Shares) at Mar. 31, 2025         66,945      
Balance at Dec. 31, 2024 $ 200 $ 308 59,649,645 $ (397,969) (52,373,248) (2,137,789) 4,741,147
Balance (in Shares) at Dec. 31, 2024 2,000,000 3,076,274 139          
Balance (in Shares) at Dec. 31, 2024         66,945      
Net loss for the period               (2,976,299)
Balance at Jun. 30, 2025 $ 200 $ 428 64,676,721 $ (397,969) (55,063,316) (2,605,550) 6,610,514
Balance (in Shares) at Jun. 30, 2025 2,000,000 4,276,274 139          
Balance (in Shares) at Jun. 30, 2025         66,945      
Balance at Mar. 31, 2025 $ 200 $ 428 64,525,389 $ (397,969) (53,846,444) (2,472,513) 7,809,091
Balance (in Shares) at Mar. 31, 2025 2,000,000 4,276,274 139          
Balance (in Shares) at Mar. 31, 2025         66,945      
Accretion of stock-based compensation in connection with stock option grants 157,120 157,120
Changes in noncontrolling interest (7,280) 7,280
Accretion of stock-based professional fees in connection with stock option grants 1,492 1,492
Net loss for the period (1,216,872) (140,317) (1,357,189)
Balance at Jun. 30, 2025 $ 200 $ 428 64,676,721 $ (397,969) (55,063,316) (2,605,550) 6,610,514
Balance (in Shares) at Jun. 30, 2025 2,000,000 4,276,274 139          
Balance (in Shares) at Jun. 30, 2025         66,945      
Balance at Dec. 31, 2025 $ 433 61,482,739 $ (397,969) (54,980,520) $ 6,104,683
Balance (in Shares) at Dec. 31, 2025 4,331,274 139          
Balance (in Shares) at Dec. 31, 2025         66,945     66,945
Accretion of stock-based compensation in connection with stock option grants 225,861 $ 225,861
Accretion of stock-based professional fees in connection with stock option grants 6,104 6,104
Issuance of common shares for services $ 6 110,994 111,000
Issuance of common shares for services (in Shares)   60,000            
Issuance of warrants for services 279,975 279,975
Net loss for the period (2,861,610) (2,861,610)
Balance at Mar. 31, 2026 $ 439 62,105,673 $ (397,969) (57,842,130) 3,866,013
Balance (in Shares) at Mar. 31, 2026 4,391,274 139          
Balance (in Shares) at Mar. 31, 2026         66,945      
Balance at Dec. 31, 2025 $ 433 61,482,739 $ (397,969) (54,980,520) $ 6,104,683
Balance (in Shares) at Dec. 31, 2025 4,331,274 139          
Balance (in Shares) at Dec. 31, 2025         66,945     66,945
Net loss for the period               $ (5,911,974)
Balance at Jun. 30, 2026 $ 526 65,663,594 $ (397,969) (60,892,494) $ 4,373,657
Balance (in Shares) at Jun. 30, 2026   5,263,375 139          
Balance (in Shares) at Jun. 30, 2026         66,945     66,945
Balance at Mar. 31, 2026 $ 439 62,105,673 $ (397,969) (57,842,130) $ 3,866,013
Balance (in Shares) at Mar. 31, 2026 4,391,274 139          
Balance (in Shares) at Mar. 31, 2026         66,945      
Accretion of stock-based compensation in connection with stock option grants 228,370 228,370
Issuance of common stock for cash, net of allocated offering costs $ 75 3,063,592 3,063,667
Issuance of common stock for cash, net of allocated offering costs (in Shares)   750,000            
Accretion of stock-based professional fees in connection with stock option grants 6,171 6,171
Issuance of common shares for services $ 12 259,788 259,800
Issuance of common shares for services (in Shares)   122,101            
Net loss for the period (3,050,364) (3,050,364)
Balance at Jun. 30, 2026 $ 526 $ 65,663,594 $ (397,969) $ (60,892,494) $ 4,373,657
Balance (in Shares) at Jun. 30, 2026   5,263,375 139          
Balance (in Shares) at Jun. 30, 2026         66,945     66,945